This grant is for advancing research in pediatric drug development. It seeks applications to address crucial research needs concerning the creation and acceptability of drug formulations specifically tailored for children across various age groups. A key focus is on ensuring these formulations are appropriate and well-received by young patients. Additionally, the initiative supports the development and rigorous testing of innovative drug delivery systems designed to improve medication administration and efficacy in pediatric populations. The overall aim is to enhance therapeutic options and outcomes for children by addressing the unique challenges associated with pediatric pharmacology and drug delivery.
Opportunity ID: 292825
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-17-193 |
| Funding Opportunity Title: | Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.865 — Child Health and Human Development Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 29, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 07, 2020 |
| Current Closing Date for Applications: | May 07, 2020 |
| Archive Date: | Jun 12, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) For profit organizations other than small businesses County governments Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages grant applications to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. Development and testing of novel pediatric drug delivery systems is also part of this initiative. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-17-193.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | Use for due dates on or before January 24, 2018 | PKG00231696 | May 05, 2017 | Jan 24, 2018 | View | |
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00235937 | Nov 08, 2017 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259259 | May 05, 2017 | May 07, 2020 | View |
Package 1
Mandatory forms
292825 RR_SF424_2_0-2.0.pdf
292825 PHS398_CoverPageSupplement_3_0-3.0.pdf
292825 RR_OtherProjectInfo_1_3-1.3.pdf
292825 PerformanceSite_2_0-2.0.pdf
292825 RR_KeyPersonExpanded_2_0-2.0.pdf
292825 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
292825 RR_Budget_1_3-1.3.pdf
292825 RR_SubawardBudget30_1_3-1.3.pdf
292825 PHS398_ModularBudget_1_2-1.2.pdf
292825 PHS_Inclusion_Enrollment_Report-1.0.pdf
292825 PHS_AssignmentRequestForm-1.0.pdf
Package 2
Mandatory forms
292825 RR_SF424_2_0-2.0.pdf
292825 PHS398_CoverPageSupplement_4_0-4.0.pdf
292825 RR_OtherProjectInfo_1_4-1.4.pdf
292825 PerformanceSite_2_0-2.0.pdf
292825 RR_KeyPersonExpanded_2_0-2.0.pdf
292825 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
292825 RR_Budget_1_4-1.4.pdf
292825 RR_SubawardBudget30_1_4-1.4.pdf
292825 PHS398_ModularBudget_1_2-1.2.pdf
292825 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 3
Mandatory forms
292825 RR_SF424_2_0-2.0.pdf
292825 PHS398_CoverPageSupplement_5_0-5.0.pdf
292825 RR_OtherProjectInfo_1_4-1.4.pdf
292825 PerformanceSite_2_0-2.0.pdf
292825 RR_KeyPersonExpanded_2_0-2.0.pdf
292825 PHS398_ResearchPlan_4_0-4.0.pdf
292825 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
292825 RR_Budget_1_4-1.4.pdf
292825 RR_SubawardBudget30_1_4-1.4.pdf
292825 PHS398_ModularBudget_1_2-1.2.pdf
292825 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
